Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
NCT Number: NCT06342063
This prospective feasibility study is designed to assess pre-operative BFR in patients awaiting ACL reconstruction. This study will serve the following: (1) to determine if BFR improves strength testing prior to surgery and (2) to determine if BFR reduces QF muscle group atrophy prior to surgery. Additionally, preliminary results on pre-operative clinical and quality of life scores will be collected. If this study shows encouraging results, it will serve as a template for a more comprehensive randomized control trial.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M5G 1X5, Canada
Quadriceps femoris (QF) muscle function is an integral factor in the rehabilitation and overall outcome after lower extremity injury or surgical intervention. Atrophy of this muscle group is a common finding in patients undergoing anterior cruciate ligament (ACL) reconstruction. This is due to the immobility prior to surgery, vascular ischemia caused by a tourniquet intra-operatively and inability to perform high load strength training in the early post-operative period. A deficit in QF muscle strength can result in excessive joint loading and be a contributing factor in the early onset of osteoarthritis of the knee. It should be noted that a loss of strength in this primary knee extensor mechanism muscle group can persist for up to 2 years after surgery. Thus, the reduction of QF atrophy and maintenance of strength during an intervention such as an ACL reconstruction has large implications for the overall post-operative outcome and natural history of the knee joint.
In order to combat the challenges of muscle atrophy for patients with an ACL injury, blood flow restriction (BFR) training has been shown to have beneficial effects in the post-operative period specifically. The process of using BFR therapy involves the application of an extremity tourniquet to occlude venous outflow and restrict arterial inflow. Thus, an anaerobic environment is created to promote muscle hypertrophy by having cells upregulate cell signalling, protein synthesis and ultimately myogenic proliferation. The use of BFR during lower extremity rehabilitation has shown that its simultaneous use with low load resistance training can have similar hypertrophic effects to isolated high load resistance training. This is ideal for patients who are initially unable to perform high intensity exercises shortly after an ACL reconstruction surgery, but are attempting to reduce overall QF atrophy.
However, the use of BFR in the pre-operative period has yet to be well established. Preconditioning with an ischemic environment may provide an effective way to reduce QF atrophy with low load exercises while awaiting surgery. Additionally, having a period of sensitization with anaerobic conditions prior to surgery, may provide some resistance to the damaging effects of a tourniquet intra-operatively. The limited studies that have attempted to use BFR therapy prior to ACL surgery have had short intervention periods, small sample sizes and outcome variables that have not assessed overall clinical outcome. If BFR in the pre-operative setting can be shown to provide beneficial effects, it will be a valuable tool in maximizing the overall outcome of patients undergoing ACL reconstruction.
This prospective feasibility study has been designed to assess pre-operative BFR in patients awaiting ACL reconstruction. This study will serve the following: (1) to determine if BFR improves strength testing prior to surgery and (2) to determine if BFR reduces QF muscle group atrophy prior to surgery. Additionally, preliminary results on pre-operative clinical and quality of life scores will be collected. If this study shows encouraging results, it will serve as a template for a more comprehensive randomized control trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
▪ Active extension deficit <5o, Active flexion > 120o
Exclusion criteria
Patients wear a personalized tourniquet pressure system on their involved thigh while they perform a series of leg press machine exercises. This tourniquet is inflated.
Other names: BFR
Patients wear a personalized tourniquet pressure system on their involved thigh while they perform a series of leg press machine exercises. This tourniquet is not inflated.
Other names: Sham BFR Comparison Group
Time frame: Baseline testing 1 day prior to physiotherapy initiation and Post intervention testing performed 1 day after physiotherapy completion but before ACL surgery.
Quadriceps and Hamstring Muscle Strength and Endurance testing. Maximal peak torque (FT-LBS) was recorded for both knee flexion and extension at 60 degrees / second (indicative of strength) and 180 degrees / second (indicative of endurance).
Time frame: Baseline testing 1 day prior to physiotherapy initiation and Post intervention testing performed 1 day after physiotherapy completion but before ACL surgery.
Patient Reported Outcome Measure. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.
Time frame: Baseline testing 1 day prior to physiotherapy initiation and Post intervention testing performed 1 day after physiotherapy completion but before ACL surgery.
Patient Reported Outcome Measure. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems.
Women's College Hospital
Other
The Effects of Preoperative Blood Flow Restriction Training in Patients Undergoing ACL Reconstruction: A Pilot Randomized Control Trial
Acronym: BFRACL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06162130
ACL Injury, Anterior Cruciate Ligament Injuries
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05218993
ACL Injury, Anterior Cruciate Ligament Injuries
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07723625
ACL Injury, ACL Tear
Denpasar, Bali, Indonesia
View Trial DetailsNCT03462823
ACL, ACL - Anterior Cruciate Ligament Rupture
Zurich, Switzerland
View Trial Details